Navigation Links
Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
Date:10/7/2008

ater this year. In addition, RDEA119 is being evaluated in a Phase 1 trial in patients with advanced cancer, and will be also be evaluated in a Phase 1/2 clinical trial in the fourth quarter of 2008 in combination with Nexavar(R) (sorafenib) in advanced cancer patients. The Company also plans to initiate a Phase 1 trial of RDEA436, its second-generation MEK inhibitor, in healthy volunteers, in the fourth quarter of this year.

About RDEA119 and RDEA436

RDEA119 and RDEA436, non-ATP competitive, highly-selective MEK inhibitors for the treatment of cancer and inflammatory diseases, are two of the compounds from Ardea's MEK inhibitor research and development program. RDEA119 has shown potential as a potent and selective inhibitor of MEK, which is believed to play an important role in cancer cell proliferation, apoptosis and metastasis. Preclinical and clinical results suggest that RDEA119 has favorable properties, including oral dosing, excellent selectivity and limited retention in the brain, which, in turn, may result in a reduced risk of central nervous system (CNS) side effects. Preclinical data show that RDEA436 is a potent in-vitro and in-vivo inhibitor of MEK, has favorable pharmacokinetic properties with low CNS penetration and a long half-life in a human micro-dose study indicating the potential for once daily dosing in humans.

About Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of HIV, gout, cancer and inflammatory diseases. We have five product candidates in clinical trials and others in preclinical development and discovery. Our most advanced product candidate is RDEA806, a non-nucleoside reverse transcriptase inhibitor (NNRTI), which has successfully completed a Phase 2a study for the treatment of patients with HIV. We have evaluated our second-generation NNRTI for the treatment of HIV,
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
2. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
3. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
4. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
5. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
6. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
7. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
10. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
11. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Landauer, Inc. (NYSE: ... and environmental radiation measurement and monitoring, outsourced medical physics ... that William E. Saxelby , its President and ... and Chief Executive Officer and as a member of ... 2014.  He will be replaced on an interim basis ...
(Date:8/21/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record in ... laboratory services companies. She has more than 20 years ... she held the position of Director, Lab Services Sales ...
(Date:8/21/2014)... /CNW/ - Eisai Limited is pleased to support the Canadian ... book available in Canada . The comic ... educate children and their parents about epilepsy, the most common ... than 300,000 Canadians. Eisai is guided by a corporate philosophy ... the patient is central – there was a need within ...
Breaking Medicine Technology:Landauer, Inc. Announces Executive Management Change 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... YORK, Aug. 30, 2011 Reportlinker.com announces that ... in its catalogue: Pharmaceutical ... http://www.reportlinker.com/p0605649/Pharmaceutical-Distributors---Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory This register contains ... Europe. The register includes the following information ...
... 2011 Simon Orobor, owner of Power Wheelchair Services, ... added U-Haul truck and trailer rentals to the power ... been operating since 2009. (Logo: http://photos.prnewswire.com/prnh/20090622/LA34860LOGO-b ... photo accompanying this press release. Families ...
Cached Medicine Technology:Power Wheelchair Services, Inc. Assists Customers in More Ways Than One With U-Haul Products and Services 2Power Wheelchair Services, Inc. Assists Customers in More Ways Than One With U-Haul Products and Services 3
(Date:8/22/2014)... attained the distinguished Magnet hospital designation by the ... Considered the gold standard for nursing excellence, the ... professionalism. It is the top international credential for ... Newport Hospital was based on the hospital,s continued ... , "It is a privilege for us to ...
(Date:8/22/2014)... may do little to help young people with drinking ... studies that included nearly 18,000 people 25 and younger, ... problems. Participants in 49 studies attended a single one-on-one ... studies attended group sessions or a mix of group ... interviewing was used in the studies. This technique was ...
(Date:8/22/2014)... previous few years, several breakthrough treatments have become ... who may benefit from these treatments can be ... their cancer. For example, patients whose lung cancer ... derive significant benefit from the drug crizotinib, which ... now attempting to replicate this success by matching ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 ItsHot.com, a ... now offering 60-80% off on its range of beautiful ... the purchase of Gold Hearts 14K White Rose Gold ... a discount of 77%. Previously priced at $3,715.00, ... $859.00. The item code of this mesmerizing pendant embedded ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 “Dr. Luciana ... Luciana Lagana , aka Dr. Luciana, is finding it challenging ... budget and while taking care of hundreds of students, so ... trailer for the show is completed, and she recently entered ... fun projects including those of her husband, actor/screenwriter Gregory ...
Breaking Medicine News(10 mins):Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Counseling Does Little to Deter Youth Drinking, Review Finds 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 3Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 4Health News:ItsHot.com Now Offers 60-80% Discount on its Striking Collection of Diamond Heart Pendants 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4
... of new guidelines for cardiac specialists has been developed ... mechanical heart-pumping device. "The new guidelines will likely ... device, and how early in the process a physician ... Jeffrey A. Morgan, M.D., associate director of Mechanical Circulatory ...
... HealthDay Reporter , FRIDAY, April 15 (HealthDay News) -- ... showing early signs of dementia, researchers from the University of ... diagnose which type of dementia a patient has and start ... dementia patients tended to have difficulty identifying the form of ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, ... chronic urinary tract infections, but now a new treatment ... a preliminary trial indicates. Urinary tract infections frequently ... all women. The depletion of vaginal Lactobacillus crispatus ...
... , FRIDAY, April 15 (HealthDay News) -- Teens who start ... traffic crashes, a new study finds. But starting the ... and reduce impulsiveness, another study finds. In 2008, the ... Beach, Va., was about 41 percent higher than for the ...
... Steven Reinberg HealthDay Reporter , THURSDAY, April 14 ... increase in hard times and decrease during years of prosperity, ... of people jumping from windows after the stock market crash ... the U.S. Centers for Disease Control and Prevention. "The ...
... A study in the April 15 issue of the Journal ... teen drivers who start school earlier in the morning. Results ... 18-year-olds was about 41 percent higher in Virginia Beach, Va., where ... adjacent Chesapeake, Va., where classes started at 8:40 - 8:45 a.m. ...
Cached Medicine News:Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 3Health News:New Treatment for Urinary Tract Infections Called Promising 2Health News:New Treatment for Urinary Tract Infections Called Promising 3Health News:Early School Start Tied to More Teen Crashes: Study 2Health News:Suicide Rates Rise and Fall With the Economy: CDC 2Health News:Suicide Rates Rise and Fall With the Economy: CDC 3Health News:Crash rates may be higher for teen drivers who start school earlier in the morning 2Health News:Crash rates may be higher for teen drivers who start school earlier in the morning 3
Titanium forceps with gently curved jaws and ultra fine sharpened tips for puncture and grasping the capsule. Round handle is excellent for precise finger-tip control...
Straight shafts with 4 mm jaws. Serrated handle with dull finish. Jaws angled 45 degrees....
Straight shafts with fine tips and dull finish. Insulated stop with tip gap set at 0.3 mm. Smooth handle....
Straight shafts with rounded tips. Smooth handle with dull finish....
Medicine Products: